Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2015-11, Vol.50 (11), p.1487-1489
Hauptverfasser:	Nelson, R, Shapiro, J F, Perkins, J B, Kim, J, Nishihori, T, Pidala, J, Ayala, E, Locke, F L, Field, T, Mishra, A, Riches, M, Betts, B, Perez, L, Yue, B, Ochoa-Bayona, J L, Alsina, M, Fernandez, H, Anasetti, C, Kharfan-Dabaja, M A
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/1904 692/700/565/2319 Adult Aged Antibiotic prophylaxis Antilymphocyte serum Antilymphocyte Serum - therapeutic use Bone marrow Cell Biology Complications and side effects Female Globulins Graft rejection Graft Survival Graft vs Host Disease - prevention & control Graft-versus-host reaction Health aspects Hematology Hematopoietic Stem Cell Transplantation Histocompatibility Histocompatibility antigen HLA HLA antigens Humans Immunosuppressive Agents - therapeutic use Internal Medicine letter-to-the-editor Male Medicine Medicine & Public Health Methods Middle Aged Prevention Prophylaxis Public Health Rapamycin Retrospective Studies Sirolimus - therapeutic use Stem cell transplantation Stem Cells T-Lymphocytes - immunology Tacrolimus Tacrolimus - therapeutic use Thymocytes Transplantation Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!